As we enter 2022, we are approaching the two-year anniversary of the COVID-19 pandemic spreading acr...
Read moreReviewing previous HTA submissions can provide valuable insights that can help manufacturers prepare...
Read moreThis article discusses updates to the orphan drugs and diseases landscapes, the challenges and incen...
Read moreIn the US, an Act recently passed through the House of Representatives which plans to expand afforda...
Read morePatent cliff refers to a sharp decline in revenue or profitability when a firm’s patents expire, o...
Read moreOur experts reflect on the pricing and market access trends that shaped the European Landscape in 20...
Read moreDigital therapeutics (DTx) is a category of digital health, which is defined as products that delive...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreWhen making a decision about the approval of a new product NICE (National Institute for Health and C...
Read more